In support of the The American Brain Tumor Association (ABTA), Immunomic Therapeutics will be sponsoring a day-long event in Washington, DC that will consist of brain tumor specialists who will share their knowledge and recommendations, a patient and caregiver panel to share their journeys, roundtables that promote interactive sharing, and learning about the latest advances and treatments including new therapies, new devices and clinical trials, and resources.